1. Home
  2. IMXI vs MLYS Comparison

IMXI vs MLYS Comparison

Compare IMXI & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • MLYS
  • Stock Information
  • Founded
  • IMXI 1994
  • MLYS 2019
  • Country
  • IMXI United States
  • MLYS United States
  • Employees
  • IMXI N/A
  • MLYS N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMXI Technology
  • MLYS Health Care
  • Exchange
  • IMXI Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • IMXI 619.2M
  • MLYS 634.6M
  • IPO Year
  • IMXI N/A
  • MLYS 2023
  • Fundamental
  • Price
  • IMXI $20.60
  • MLYS $9.77
  • Analyst Decision
  • IMXI Buy
  • MLYS Strong Buy
  • Analyst Count
  • IMXI 6
  • MLYS 2
  • Target Price
  • IMXI $27.50
  • MLYS $30.00
  • AVG Volume (30 Days)
  • IMXI 129.9K
  • MLYS 266.6K
  • Earning Date
  • IMXI 02-25-2025
  • MLYS 11-11-2024
  • Dividend Yield
  • IMXI N/A
  • MLYS N/A
  • EPS Growth
  • IMXI 21.49
  • MLYS N/A
  • EPS
  • IMXI 1.80
  • MLYS N/A
  • Revenue
  • IMXI $665,673,000.00
  • MLYS N/A
  • Revenue This Year
  • IMXI $2.65
  • MLYS N/A
  • Revenue Next Year
  • IMXI $2.82
  • MLYS N/A
  • P/E Ratio
  • IMXI $11.47
  • MLYS N/A
  • Revenue Growth
  • IMXI 3.79
  • MLYS N/A
  • 52 Week Low
  • IMXI $16.17
  • MLYS $8.58
  • 52 Week High
  • IMXI $23.28
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 48.63
  • MLYS 37.52
  • Support Level
  • IMXI $19.73
  • MLYS $9.18
  • Resistance Level
  • IMXI $21.41
  • MLYS $9.97
  • Average True Range (ATR)
  • IMXI 0.47
  • MLYS 0.85
  • MACD
  • IMXI 0.03
  • MLYS -0.25
  • Stochastic Oscillator
  • IMXI 51.94
  • MLYS 24.53

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: